| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |